JPWO2020180741A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020180741A5
JPWO2020180741A5 JP2021549902A JP2021549902A JPWO2020180741A5 JP WO2020180741 A5 JPWO2020180741 A5 JP WO2020180741A5 JP 2021549902 A JP2021549902 A JP 2021549902A JP 2021549902 A JP2021549902 A JP 2021549902A JP WO2020180741 A5 JPWO2020180741 A5 JP WO2020180741A5
Authority
JP
Japan
Prior art keywords
cancer
target
item
stranded
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521781A5 (https=
JP2022521781A (ja
JP7344973B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020529 external-priority patent/WO2020180741A1/en
Publication of JP2022521781A publication Critical patent/JP2022521781A/ja
Publication of JP2022521781A5 publication Critical patent/JP2022521781A5/ja
Publication of JPWO2020180741A5 publication Critical patent/JPWO2020180741A5/ja
Application granted granted Critical
Publication of JP7344973B2 publication Critical patent/JP7344973B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549902A 2019-03-01 2020-02-28 標的実体を検出するためのシステム、組成物、及び方法 Active JP7344973B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962812878P 2019-03-01 2019-03-01
US62/812,878 2019-03-01
US202062962722P 2020-01-17 2020-01-17
US62/962,722 2020-01-17
PCT/US2020/020529 WO2020180741A1 (en) 2019-03-01 2020-02-28 Systems, compositions, and methods for target entity detection

Publications (4)

Publication Number Publication Date
JP2022521781A JP2022521781A (ja) 2022-04-12
JP2022521781A5 JP2022521781A5 (https=) 2023-03-09
JPWO2020180741A5 true JPWO2020180741A5 (https=) 2023-03-09
JP7344973B2 JP7344973B2 (ja) 2023-09-14

Family

ID=72338354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021549902A Active JP7344973B2 (ja) 2019-03-01 2020-02-28 標的実体を検出するためのシステム、組成物、及び方法

Country Status (9)

Country Link
US (3) US11085089B2 (https=)
EP (2) EP3931351B1 (https=)
JP (1) JP7344973B2 (https=)
KR (1) KR102599718B1 (https=)
CN (1) CN113748217B (https=)
AU (2) AU2020233286B2 (https=)
CA (1) CA3129868A1 (https=)
SG (1) SG11202109423TA (https=)
WO (1) WO2020180741A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020233286B2 (en) 2019-03-01 2022-10-20 Mercy Bioanalytics, Inc. Systems, compositions, and methods for target entity detection
DE102020003794A1 (de) * 2020-06-25 2021-12-30 Forschungszentrum Jülich GmbH Verfahren, Verwendung des Verfahrens sowle Kit zum Nachweis von Bioindikatoren in einer Probe
EP4301782A1 (en) 2021-03-05 2024-01-10 Go Therapeutics, Inc. Anti-glyco-cd44 antibodies and their uses
EP4373975A4 (en) * 2021-07-21 2025-04-23 Mercy Bioanalytics, Inc. COMPOSITIONS AND METHODS FOR THE DETECTION OF PANCREATIC CANCER
US20250297317A1 (en) * 2021-07-21 2025-09-25 Mercy Bioanalytics, Inc. Compositions and methods for detection of liver cancer
WO2023004083A2 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for detection of bile duct cancer
US20250043357A1 (en) * 2021-07-21 2025-02-06 Mercy Bioanalytics, Inc. Compositions and methods for detection of esophageal cancer
EP4373860A4 (en) * 2021-07-21 2025-05-21 Mercy Bioanalytics, Inc. COMPOSITIONS AND METHODS FOR THE DETECTION OF PROSTATE CANCER
EP4374172A4 (en) * 2021-07-21 2025-05-14 Mercy Bioanalytics, Inc. COMPOSITIONS AND METHODS FOR DETECTING BREAST CANCER
EP4374173A4 (en) * 2021-07-21 2026-02-25 Mercy Bioanalytics Inc CANCER COMPOSITIONS AND DETECTION METHODS
WO2023004077A2 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for detection of colorectal cancer
JP2024531915A (ja) 2021-08-05 2024-09-03 ジーオー セラピューティクス,インコーポレイテッド 抗グリコmuc抗体およびその使用
CA3230934A1 (en) 2021-09-03 2023-03-09 Go Therapeutics, Inc. Anti-glyco-cmet antibodies and their uses
AU2022339819A1 (en) 2021-09-03 2024-04-11 Go Therapeutics, Inc. Anti-glyco-lamp1 antibodies and their uses
WO2023091618A1 (en) * 2021-11-17 2023-05-25 Mercy Bioanalytics, Inc. Compositions and methods for detection of ovarian cancer
EP4623094A1 (en) * 2022-11-23 2025-10-01 Range Biotechnologies, Inc. Compositions and methods for detection of protein analytes
WO2025252658A1 (en) 2024-06-03 2025-12-11 Olink Proteomics Ab New product and method

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795714A (en) * 1992-11-06 1998-08-18 Trustees Of Boston University Method for replicating an array of nucleic acid probes
CA2118759C (en) 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood
US20020025519A1 (en) * 1999-06-17 2002-02-28 David J. Wright Methods and oligonucleotides for detecting nucleic acid sequence variations
US7306904B2 (en) 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
US8013134B2 (en) 2001-11-23 2011-09-06 Olink Ab Kit for proximity probing with multivalent proximity probes
AU2004232976B2 (en) 2003-04-18 2011-02-10 Becton, Dickinson And Company Immuno-amplification
DK1633888T3 (da) * 2003-06-17 2009-07-13 Keygene Nv Midler og fremgangsmåde til påvisning af målnucleotidsekvenser under anvendelse af ligeringsassays med forbedrede oligonucleotidprobepar
US7914987B2 (en) 2004-06-14 2011-03-29 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for use in analyte detection using proximity probes
GB0605584D0 (en) 2006-03-20 2006-04-26 Olink Ab Method for analyte detection using proximity probes
US8758991B2 (en) 2006-04-26 2014-06-24 University Of Louisville Research Foundation, Inc. Isolation of membrane vesicles from biological fluids and methods of using same
US7892760B2 (en) 2007-11-19 2011-02-22 Celera Corporation Lung cancer markers, and uses thereof
US8481698B2 (en) 2009-03-19 2013-07-09 The President And Fellows Of Harvard College Parallel proximity ligation event analysis
GB201004292D0 (en) 2010-03-15 2010-04-28 Olink Ab Assay for localised detection of analytes
EP2627781B1 (en) 2010-10-15 2017-02-22 Olink Bioscience AB Dynamic range methods
JP6219721B2 (ja) 2010-11-10 2017-10-25 エキソソーム ダイアグノスティックス インコーポレイテッド 核酸含有粒子の単離および該粒子からの核酸の抽出のための方法
GB201101621D0 (en) 2011-01-31 2011-03-16 Olink Ab Method and product
CA2835641C (en) 2011-05-11 2019-05-28 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
US9745616B2 (en) * 2011-05-17 2017-08-29 Dxterity Diagnostics Incorporated Methods and compositions for detecting target nucleic acids
GB201108678D0 (en) 2011-05-24 2011-07-06 Olink Ab Multiplexed proximity ligation assay
EP2776587A4 (en) 2011-11-10 2015-07-15 Exosome Diagnostics Inc LIQUOR ASSAY
US9029086B2 (en) 2012-01-26 2015-05-12 Masood Kamali Moghaddam Detection of single and multimodal analytes
WO2014015149A2 (en) 2012-07-18 2014-01-23 Exosome Diagnostics, Inc. Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
CA2887058C (en) 2012-10-03 2022-02-22 Exosome Diagnostics, Inc. Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
WO2014076209A1 (en) 2012-11-14 2014-05-22 Olink Ab Localised rca-based amplification method
WO2014076214A1 (en) 2012-11-14 2014-05-22 Olink Ab Rca reporter probes and their use in detecting nucleic acid molecules
US9086412B2 (en) 2012-12-31 2015-07-21 University Of Louisville Research Foundation, Inc. Extracellular vesicle-associated protein markers of cancer
EP2941629B1 (en) 2013-01-03 2018-10-10 Exosome Diagnostics Inc. Methods for isolating microvesicles
AU2014305994B2 (en) 2013-08-06 2019-02-21 Exosome Diagnostics, Inc. Urine biomarker cohorts, gene expression signatures, and methods of use thereof
AU2014312211A1 (en) * 2013-08-28 2016-03-10 Caris Science, Inc. Oligonucleotide probes and uses thereof
CN105745334B (zh) 2013-09-30 2019-12-10 吴迪 通过使用邻近条形编码分析分子复合物的概况的方法
GB201401885D0 (en) 2014-02-04 2014-03-19 Olink Ab Proximity assay with detection based on hybridisation chain reaction (HCR)
EP3366784B1 (en) 2014-02-28 2019-11-13 Exosome Sciences Inc. Brain specific exosome based diagnostics and extracorporeal therapies
WO2015175856A1 (en) * 2014-05-15 2015-11-19 Meso Scale Technologies, Llc. Improved assay methods
AU2015269103B2 (en) * 2014-06-06 2021-12-23 Cornell University Method for identification and enumeration of nucleic acid sequence, expression, copy, or DNA methylation changes, using combined nuclease, ligase, polymerase, and sequencing reactions
WO2015193427A1 (en) 2014-06-19 2015-12-23 Olink Ab Determination and analysis of biomarkers in clinical samples
JP2017537657A (ja) 2014-12-11 2017-12-21 ニユー・イングランド・バイオレイブス・インコーポレイテツド 標的配列の濃縮
US11175286B2 (en) * 2015-01-09 2021-11-16 Spot Biosystems Ltd. Immunolipoplex nanoparticle biochip containing molecular probes for capture and characterization of extracellular vesicles
WO2016145128A1 (en) * 2015-03-09 2016-09-15 Caris Science, Inc. Oligonucleotide probes and uses thereof
CN114217058A (zh) * 2015-09-22 2022-03-22 波士顿大学董事会 纳米囊泡的多重表型分析
GB201518655D0 (en) 2015-10-21 2015-12-02 Olink Ab Method for generating proximity probes
US10526665B2 (en) * 2016-03-04 2020-01-07 University Of Notre Dame Du Lac Exosomal biomarkers diagnostic of tuberculosis
PT3464628T (pt) * 2016-06-06 2024-06-03 Redvault Biosciences Lp Construções repórter de alvo e suas utilizações
JP7280823B2 (ja) * 2016-11-30 2023-05-24 エクソサム ダイアグノスティクス,インコーポレイティド 非小細胞肺癌患者由来のエクソソームrna及び無細胞dnaを使用して血漿中の変異を検出するための方法と組成物
WO2018119455A1 (en) 2016-12-23 2018-06-28 Exosome Diagnostics, Inc. Biofluid analysis and quantitation systems and methods
US11899024B2 (en) 2017-07-12 2024-02-13 Exosome Diagnostics, Inc. Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles
WO2019018537A1 (en) 2017-07-18 2019-01-24 Exosome Diagnostics, Inc. NUCLEIC ACID SEQUENCING ASSOCIATED WITH EXOSOMAL ISOLATION IN PATIENTS WITH MULTIPLE GLIOBLASTOMA
WO2019022542A2 (ko) 2017-07-26 2019-01-31 ㈜로제타엑소좀 양이온을 이용한 세포밖 소포체의 분리 방법
EP3660142A4 (en) 2017-07-26 2021-05-05 Rosetta Exosome METHOD OF ISOLATION OF EXTRACELLULAR VESICLES USING CATIONS
WO2019066501A1 (ko) 2017-09-27 2019-04-04 ㈜로제타엑소좀 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분석 방법 및 이의 용도
WO2019103548A2 (ko) 2017-11-24 2019-05-31 ㈜로제타엑소좀 반건식 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분리 방법
WO2019113499A1 (en) * 2017-12-07 2019-06-13 The Broad Institute, Inc. High-throughput methods for identifying gene interactions and networks
US12480940B2 (en) * 2018-05-17 2025-11-25 Meso Scale Technologies, Llc. Methods for isolating surface marker displaying agents
WO2019236853A1 (en) 2018-06-06 2019-12-12 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
WO2019238944A1 (en) 2018-06-15 2019-12-19 Olink Proteomics Ab Biomarker panel for ovarian cancer
WO2020086751A1 (en) * 2018-10-23 2020-04-30 Meso Scale Technologies, Llc. Methods for isolating surface marker displaying agents
WO2020106853A1 (en) 2018-11-20 2020-05-28 Exosome Diagnostics, Inc. Compositions and methods for internal controls of microvesicle isolations
AU2020233286B2 (en) 2019-03-01 2022-10-20 Mercy Bioanalytics, Inc. Systems, compositions, and methods for target entity detection
US20230243834A1 (en) * 2020-01-17 2023-08-03 Mercy Bioanalytics, Inc. Compositions and methods for detection of ovarian cancer

Similar Documents

Publication Publication Date Title
CN104620109B (zh) 膀胱癌检测组合物、试剂盒及相关的方法
JPWO2020180741A5 (https=)
ES2492498T3 (es) Panel de biomarcadores para el diagnóstico y la predicción de rechazo de injerto
US11827938B2 (en) Methods of prostate cancer prognosis
US20080206756A1 (en) Biomarker panel for colorectal cancer
CA3192386A1 (en) Metastasis predictor
WO2017210372A1 (en) Molecular tagging methods and sequencing libraries
EP1339872A2 (en) Genetic markers for tumors
JP2023533970A (ja) 肺癌を検出するための組成物及び方法
CN113493829B (zh) 生物标志物在肺动脉高压诊疗中的应用
JP2010518868A (ja) 前立腺癌の生存及び再発
Macerola et al. NanoString in the screening of genetic abnormalities associated with thyroid cancer
CN113502326B (zh) 基于生物标志物的肺动脉高压的诊断产品及其应用
US20230133776A1 (en) Methods for diagnosing cancer
WO2018186687A1 (ko) 생물학적 시료의 핵산 품질을 결정하는 방법
US20250137064A1 (en) Use of multi-nucleotide and structural variants for improved sensitivity and specificity of circulating tumor dna assays
CN108913772B (zh) 基于捕获测序的bMSI检测技术
Galbraith et al. Detection of gene fusions and rearrangements in formalin-fixed, paraffin-embedded solid tumor specimens using high-throughput chromosome conformation capture
CN109642257B (zh) 药物疗法对癌的效果的预测方法
JP2023525760A (ja) 血漿および唾液のリキッドバイオプシープラットフォーム
CN113564172A (zh) 一种液体活检肿瘤细胞dna适配体
JP2007532142A (ja) 乳がん遺伝子発現バイオマーカー
KR20220126039A (ko) 대장암 재발 예측용 바이오마커 및 그 용도
US20250129428A1 (en) Methods and materials for predicting the progression of prostate cancer and treating same
JP2006166789A (ja) 癌の新規診断方法